Reply to S. Fuji

J Clin Oncol. 2020 Feb 10;38(5):523. doi: 10.1200/JCO.19.02689. Epub 2019 Dec 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Lymphoma, Follicular*
  • Progression-Free Survival
  • Rituximab

Substances

  • Rituximab